BETA DRUGS
Back to Cashflow Statement
|
BETA DRUGS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹37 Cr | ₹36 Cr | ₹31 Cr | ₹23 Cr | ₹30 Cr |
What is the latest Cash Flow from Operating Activities ratio of BETA DRUGS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹37 Cr |
| Mar2025 | ₹36 Cr |
| Mar2024 | ₹31 Cr |
| Mar2023 | ₹23 Cr |
| Mar2022 | ₹30 Cr |
How is Cash Flow from Operating Activities of BETA DRUGS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹37 Cr | 3.16 | |
| Mar2025 | ₹36 Cr | 16.86 | |
| Mar2024 | ₹31 Cr | 32.28 | |
| Mar2023 | ₹23 Cr | -21.08 | |
| Mar2022 | ₹30 Cr | - | |
Compare Cash Flow from Operating Activities of peers of BETA DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BETA DRUGS | ₹2,043.2 Cr | 2.4% | -8% | -4.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,963.0 Cr | 2.7% | 1.4% | 4.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹269,451.0 Cr | 4.5% | 6.3% | 50.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,456.0 Cr | 1.8% | -1.3% | 31.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,664.0 Cr | 0.8% | 12.5% | 14.1% | Stock Analytics | |
| CIPLA | ₹113,246.0 Cr | 1.6% | 4.4% | -9.1% | Stock Analytics | |
BETA DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BETA DRUGS | 2.4% |
-8% |
-4.7% |
| SENSEX | 7% |
9.6% |
-6.7% |
You may also like the below Video Courses